BioProtonics, Inc.

bioProtonics provides the resolving power needed to measure the ultra-fine tissue changes that are the earliest harbingers of disease, thus enabling the most effective application of therapeutics. The company was founded in 2018 and is headquartered in Santa Barbara, California, United States.